These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 3332858)

  • 21. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
    Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
    Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytogenetic and molecular analysis of a "masked" Philadelphia chromosome in chronic and blastic phases of chronic myeloid leukemia.
    Zitzelsberger H; Bauchinger M; Wilmanns W; Strauss PG
    Cancer Genet Cytogenet; 1990 Jul; 47(2):219-25. PubMed ID: 2357696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of M-bcr breakpoint with different chromosomal abnormalities in blast crisis Ph1-positive CML.
    Mills KI; Stewart J; Burnett AK
    Leuk Res; 1991; 15(11):999-1003. PubMed ID: 1961015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variability of the molecular defects corresponding to the presence of a Philadelphia chromosome in human hematologic malignancies.
    Saglio G; Guerrasio A; Tassinari A; Ponzetto C; Zaccaria A; Testoni P; Celso B; Rege Cambrin G; Serra A; Pegoraro L
    Blood; 1988 Oct; 72(4):1203-8. PubMed ID: 3167203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of Philadelphia chromosome-negative BCR-ABL-positive chronic myelogenous leukemia by hypermetaphase fluorescence in situ hybridization.
    Seong D; Kantarjian HM; Albitar M; Arlinghaus R; Xu J; Talpaz M; Rios MB; Guo JQ; O'Brien S; Siciliano M
    Ann Oncol; 1999 Aug; 10(8):955-9. PubMed ID: 10509158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ABL proteins in Philadelphia-positive acute leukaemias and chronic myelogenous leukaemia blast crises.
    Ponzetto C; Guerrasio A; Rosso C; Avanzi G; Tassinari A; Zaccaria A; LoCoco F; Foa R; Basso G; Abate ML
    Br J Haematol; 1990 Sep; 76(1):39-44. PubMed ID: 2223647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The molecular biology of chronic myeloid leukaemia.
    Melo JV
    Leukemia; 1996 May; 10(5):751-6. PubMed ID: 8656667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cytogenetic and molecular studies in patients with chronic myelogenous leukemia without Ph chromosome and with unusual Ph translocation].
    Xue YQ
    Zhonghua Yi Xue Za Zhi; 1993 Apr; 73(4):209-12, 252-3. PubMed ID: 8395313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
    Steinberg M
    Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Additional clonal abnormalities in Philadelphia-positive ALL and CML demonstrate a different cytogenetic pattern at diagnosis and follow different pathways at progression.
    Bacher U; Haferlach T; Hiddemann W; Schnittger S; Kern W; Schoch C
    Cancer Genet Cytogenet; 2005 Feb; 157(1):53-61. PubMed ID: 15676148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rearrangement of the breakpoint cluster region and expression of P210 BCR-ABL in a "masked" Philadelphia chromosome-positive acute myeloid leukemia.
    Price CM; Rassool F; Shivji MK; Gow J; Tew CJ; Haworth C; Goldman JM; Wiedemann LM
    Blood; 1988 Nov; 72(5):1829-32. PubMed ID: 3179449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of clinical, cytogenetic, and molecular aspects of Ph-negative CML.
    van der Plas DC; Grosveld G; Hagemeijer A
    Cancer Genet Cytogenet; 1991 Apr; 52(2):143-56. PubMed ID: 2021916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Philadelphia chromosome in leukemogenesis.
    Kang ZJ; Liu YF; Xu LZ; Long ZJ; Huang D; Yang Y; Liu B; Feng JX; Pan YJ; Yan JS; Liu Q
    Chin J Cancer; 2016 May; 35():48. PubMed ID: 27233483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Further evidence for the molecular heterogeneity of chronic myeloid leukemia.
    Hernandez A; Corral L; Muñiz A; Alaez C; Espinosa E; Martinez G; Hernandez P
    Ann Hematol; 1991 Jun; 62(6):217-20. PubMed ID: 1854884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic myeloid leukemia: cytogenetic methods and applications for diagnosis and treatment.
    Morris CM
    Methods Mol Biol; 2011; 730():33-61. PubMed ID: 21431633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia in Lymphoid Blast Crisis.
    Kolenova A; Maloney KW; Hunger SP
    J Pediatr Hematol Oncol; 2016 Aug; 38(6):e193-5. PubMed ID: 27164534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chronic myeloid leukemia, biological aspects].
    Costello R; Bouabdallah R; Sainty D; Gastaut JA; Gabert J
    Rev Med Interne; 1996; 17(3):213-23. PubMed ID: 8734143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.
    Onida F; Ball G; Kantarjian HM; Smith TL; Glassman A; Albitar M; Scappini B; Rios MB; Keating MJ; Beran M
    Cancer; 2002 Oct; 95(8):1673-84. PubMed ID: 12365015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative".
    Selleri L; Emilia G; Luppi M; Temperani P; Zucchini P; Tagliafico E; Artusi T; Sarti M; Donelli A; Castoldi GL
    Hematol Pathol; 1990; 4(2):67-77. PubMed ID: 2197265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.